Real-time insights. Smarter decisions. Better trades.
🔍 Search Stocks 14 day Free Trial
RHYTHM BIOSCIENCES LIMITED (RHY)ASX AI Signals has generated 7 signals for RHY during the last 90 days, indicating strong trading activity and ongoing AI monitoring
Latest RHY Signals | |
| 01/07/2026 | SELL |
| 25/06/2026 | SELL |
| 02/06/2026 | SELL |
RHY Share Price | |
| Current Price | $0.096 |
| 52 Week High | $0.255 |
| 52 Week Low: | $0.053 |
| Trading at (% of 52 Week High) | 37.65% |
Rhythm Biosciences Limited (ASX: RHY) is a medical diagnostics company specializing in the development and commercialization of novel biomarker tests. Their primary focus is on early detection and risk assessment of colorectal cancer through non-invasive diagnostic tests. The company aims to improve patient outcomes by providing accurate and accessible testing solutions.
The Health Care Equipment & Services sector on the ASX includes companies that produce medical devices, equipment, and supplies, as well as those providing healthcare-related services. This sector covers a wide range of products such as surgical instruments, diagnostic machines, and health monitoring devices. It also includes businesses involved in healthcare management, medical laboratories, and support services. These companies play a key role in supporting hospitals, clinics, and other healthcare providers to improve patient care. The sector is influenced by factors like technological advances, regulatory changes, and demand for healthcare services.
The SELL recommendation for RHY is supported by weak price momentum and potential liquidity concerns at the current low price level. However, limited publicly available financial data introduces some uncertainty, moderating the confidence level.
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But while history lauds those rare successes, those that fail The last three months have been tough on Rhythm Biosciences Limited (ASX:RHY) shareholders, who have seen the share price decline a rather worrying 54%. But over three years the performance has been really wonderful. The longer term view reveals that the share price is up 785% in that period. As lon Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But the harsh reality It might be of some concern to shareholders to see the Rhythm Biosciences Limited (ASX:RHY) share price down 18% in the last month. But that doesn't displace its brilliant performance over three years. Over that time, we've been excited to watch the share price climb an impressive 585%. As long term Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the right price. For example, biotech and mining exploration companies often lose money for years before finding success with a new treatment or mineral discovery. But while history laudLatest RHYTHM BIOSCIENCES LIMITED(RHY) News
Here's Why We're Not Too Worried About Rhythm Biosciences' (ASX:RHY) Cash Burn Situation
Those who invested in Rhythm Biosciences (ASX:RHY) three years ago are up 914%
We're Hopeful That Rhythm Biosciences (ASX:RHY) Will Use Its Cash Wisely
Rhythm Biosciences' (ASX:RHY) investors will be pleased with their massive 685% return over the last three years
Companies Like Rhythm Biosciences (ASX:RHY) Are In A Position To Invest In Growth
Get access to daily BUY & SELL signals, advanced AI analysis, watchlists and email alerts.
14 Day Free Trial • Cancel Anytime • Founders Price $15/month
Start My Free Trial